ESC Professional Premium Access

Alleviation of AF related symptoms following acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm with flecainide acetate oral inhalation solution

Congress Presentation

About the speaker

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)
56 presentations
1 follower

5 more presentations in this session

Dronedarone as early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET4 criteria

Speaker: Professor J. Piccini (Durham, US)

Thumbnail

Amiodarone and Lung Toxicity in a real-life contemporary population

Speaker: Doctor G. Tsaban (Beer Sheva, IL)

Thumbnail

Chronic amiodarone therapy and mortality among atrial fibrillation patients; insights from a real-life contemporary population

Speaker: Doctor G. Tsaban (Beer Sheva, IL)

Thumbnail

Amiodarone therapy and risk of primary lung cancer; insights from a real-life contemporary population study

Speaker: Doctor G. Tsaban (Beer Sheva, IL)

Thumbnail

Predictors of successful cardioversion of recent-onset atrial fibrillation to sinus rhythm with orally inhaled flecainide

Speaker: Doctor H. Crijns (Maastricht, NL)

Thumbnail

Access the full session

Novel medication strategies in atrial fibrillation

Speakers: Professor J. Camm, Professor J. Piccini, Doctor G. Tsaban, Doctor G. Tsaban, Doctor G. Tsaban...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk